Research Topics
| Jk ChanSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Influence of the gynecologic oncologist on the survival of ovarian cancer patientsJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics, University of California, San Francisco School of Medicine, San Francisco Comprehensive Cancer Center, San Francisco, California 94143 1702, USA
Obstet Gynecol 109:1342-50. 2007..To estimate the influence of gynecologic oncologists on the treatment and outcome of patients with ovarian cancer...
Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group studyJohn K Chan
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California 94143 1702, USA
Cancer 112:2202-10. 2008..The purpose was to identify the factors predictive of recurrence and survival in patients with high-risk (stage I, grade 3; stage IC, stage II, or clear cell) epithelial ovarian cancer after adjuvant therapy...- Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success?John K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
J Clin Oncol 26:1511-8. 2008.... - Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancerJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Services, University of California, San Francisco School of Medicine, Helen Diller Family Comprehensive Cancer Center, 94143 1702, USA
Am J Obstet Gynecol 198:216.e1-5. 2008..The purpose of this study was to evaluate the role of surgical staging in patients with grade 1 endometrioid uterine cancer... - Influence of gynecologic oncologists on the survival of patients with endometrial cancerJohn K Chan
University of California, San Francisco UCSF School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
J Clin Oncol 29:832-8. 2011..Therefore, we propose to determine the influence of gynecologic oncologists on the treatment and survival of patients with endometrial cancer... - A novel technique for the enrichment of primary ovarian cancer cellsJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, San Francisco, UCSF Comprehensive Cancer Center, 94143 1702, USA
Am J Obstet Gynecol 197:507.e1-5. 2007..We describe an efficient and effective method of enriching ovarian tumor cells from ascitic fluid using an immunomagnetic-based method... - Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United StatesJohn K Chan
Division of Gynecologic Oncology, Department of Obsetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
J Surg Oncol 97:103-7. 2008..To compare the racial differences in treatment and survival of epithelial ovarian cancer patients... - The outcomes of 27,063 women with unstaged endometrioid uterine cancerJohn K Chan
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA 94143, USA
Gynecol Oncol 106:282-8. 2007..Over two-thirds of patients with endometrioid uterine cancer in the Surveillance, Epidemiology and End Results program from 1988 to 2001 did not undergo a lymphadenectomy. These patients were compared to those who had a lymphadenectomy... - Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancerJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Comprehensive Cancer Center, 94143 1702, USA
Gynecol Oncol 108:95-9. 2008..A significant number of young patients with early-stage ovarian cancer did not receive chemotherapy based on standard practice guidelines. We investigated factors associated with the suboptimal treatment in these women... - Role of complete lymphadenectomy in endometrioid uterine cancerJohn K Chan
University of California, San Francisco Comprehensive Cancer Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, San Francisco, CA, USA
Lancet Oncol 8:831-41. 2007..Moreover, we discuss the complications associated with lymphadenectomy and identify subsets of low-risk patients who might not need to undergo this procedure... 
The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patientsJ K Chan
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, 1600 Divisadero Street, Box 1702, San Francisco, CA 94143, USA
Br J Cancer 96:1817-22. 2007..The extent of lymphadenectomy is associated with an improved disease-specific survival of women with advanced epithelial ovarian cancer...- The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?Jk Chan
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco School of Medicine, 1600 Divisadero Street, Box 1702, San Francisco, CA 94143, USA
Br J Cancer 98:1191-6. 2008..The marginal improvement in survival demonstrated over time is potentially attributed to the increased use of staging procedures with lymphadenectomy... - Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancersJohn K Chan
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
Gynecol Oncol 109:370-6. 2008..To compare the clinico-pathologic characteristics and survival of women with clear cell versus other epithelial ovarian cancers... - Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group studyJohn K Chan
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, Division of Gynecologic Oncology, San Francisco School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
Gynecol Oncol 116:307-11. 2010..This study aimed to evaluate the clinical outcome of recurrent early-stage high-risk epithelial ovarian cancer patients... - The influence of conservative surgical practices for malignant ovarian germ cell tumorsJohn K Chan
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Helen Diller Family, Comprehensive Cancer Center, San Francisco, California 94143 1702, USA
J Surg Oncol 98:111-6. 2008..To evaluate demographics, survival, and surgical trends for patients with malignant ovarian germ cell tumors... - The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group studyJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
Gynecol Oncol 116:301-6. 2010..three cycles of chemotherapy. We proposed to identify subsets of patients who may benefit from more cycles of chemotherapy... - Endometrial stromal sarcoma: a population-based analysisJ K Chan
Department of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA
Br J Cancer 99:1210-5. 2008..Ovarian-sparing surgeries may be considered in younger patients with early-stage disease... - Patterns and progress in ovarian cancer over 14 yearsJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, California 94305, USA
Obstet Gynecol 108:521-8. 2006..To estimate the change in survival rates of women with ovarian cancer during the past 14 years... - Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinomaChad A Hamilton
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305, USA
Int J Radiat Oncol Biol Phys 63:839-44. 2005..001) remained as independent prognostic factors for improved survival. CONCLUSION: Adjuvant therapy with chemotherapy or radiotherapy improves the survival of women with early-stage uterine papillary serous carcinoma... - Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deathsStefanie M Ueda
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, UCSF, School of Medicine and Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
Am J Obstet Gynecol 198:218.e1-6. 2008..The purpose of this study was to determine factors responsible for the increasing number of deaths from corpus cancer over three time periods... - Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?John K Chan
Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, University of California, Orange, California, USA
Obstet Gynecol 102:156-61. 2003..Clinical and pathologic factors responsible for survival differences between the two groups were also determined... - Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patientsJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, California 94305, USA
Cancer 107:1823-30. 2006..The purpose of the current study was to determine the potential therapeutic role of lymphadenectomy in women with endometrioid corpus cancer... - Prognostic factors for uterine cancer in reproductive-aged womenNita Karnik Lee
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94143, USA
Obstet Gynecol 109:655-62. 2007..To determine the prognostic factors that influence the survival of younger women diagnosed with uterine cancer... - The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinomaAnand Parthasarathy
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
Gynecol Oncol 103:1095-9. 2006..06). CONCLUSION: Our data suggest that adjuvant radiotherapy may improve the disease-specific survival of patients with single-node-positive vulvar cancer who underwent a less extensive lymph node resection (<or=12 nodes removed)... - Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinomaJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, Room HH333, Stanford, CA, USA
Gynecol Oncol 103:919-23. 2006..07). CONCLUSION: Our study demonstrates the safety, tolerability, and potential efficacy of Thalidomide in recurrent and refractory epithelial ovarian cancers. Additional clinical trials are warranted... - The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinomaChad A Hamilton
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305, USA
Gynecol Oncol 103:679-83. 2006..Given the overall poor prognosis of these patients, new treatment modalities are warranted... - Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patientsJoshua G Cohen
Division of Gynecologic Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA
Am J Obstet Gynecol 203:347.e1-6. 2010..To determine the clinicopathologic factors associated with survival in neuroendocrine small cell cervical cancer patients... - Adjuvant radiation therapy in stage III node-positive uterine cancerSeraina Schmid
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, Box 1702, San Francisco, CA 94143 1702, USA
Gynecol Oncol 115:239-43. 2009..To determine the association of adjuvant radiotherapy and outcomes of women with stage III node-positive uterine cancer... - Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcomeJohn K Chan
Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, University of California, Irvine, Medical Center, Orange, USA
J Reprod Med 48:756-60. 2003..The median follow-up was 80 months (range, 4-157). CONCLUSION: Conservative surgery for borderline ovarian tumors should be considered for women in the reproductive age group who desire preservation of fertility... - Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 womenMallory Zhang
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
Gynecol Oncol 104:396-400. 2007..To evaluate prognostic factors that impact on the survival of women with ovarian sex cord stromal tumors (SCST)... - Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapyVera Loizzi
Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, University of California-Irvine Medical Center, 101 The City Drive, Orange, CA 92868, USA
Am J Obstet Gynecol 189:1301-7. 2003..Randomized, prospective, controlled trials are needed... - Vulvar melanoma: a multivariable analysis of 644 patientsValerie E Sugiyama
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco School of Medicine, UCSF Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, USA
Obstet Gynecol 110:296-301. 2007..To determine the prognostic factors associated with the survival of vulvar melanoma patients... - Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysisJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, HH333, Stanford Cancer Center, Stanford, CA 94305, USA
Gynecol Oncol 96:204-9. 2005..To evaluate prognostic factors that impacts the survival of women with sex cord stromal tumors of the ovary (SCST)... - Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patientsJohn K Chan
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California at San Francisco School of Medicine, University of California, San Francisco Comprehensive Cancer Center, California 94143 1702, USA
Cancer 109:2454-60. 2007.... - Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancerAnand Parthasarathy
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94143 1702, USA
Obstet Gynecol 110:1237-43. 2007..To estimate if adjuvant radiotherapy improves the disease-specific survival of patients with clinical stage IC and II endometrioid corpus cancer who did not undergo lymphadenectomy... - Cost effectiveness of a test to detect metastases for endometrial cancerLaura J Havrilesky
Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA
Gynecol Oncol 112:526-30. 2009..To estimate the potential cost-effectiveness of a hypothetical test to screen for lymph node metastases in women with newly diagnosed, apparent early stage endometrial cancer... - Association of lymphadenectomy and survival in stage I ovarian cancer patientsJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA 94305, USA
Obstet Gynecol 109:12-9. 2007..To estimate the survival impact of lymphadenectomy in women diagnosed with clinical stage I ovarian cancer... - Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysisJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford Cancer Center, 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
Gynecol Oncol 104:636-41. 2007..To determine the importance of margin status and other prognostic factors associated with the recurrence and survival of patients with squamous cell vulvar carcinoma... - Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysisJohn K Chan
Division of Gynecologic Oncology, The Chao Family Comprehensive Cancer Center, University of California-Irvine Medical Center, Orange, California 92868, USA
Cancer 97:568-74. 2003..The role of primary or postoperative radiation with or without chemotherapy is unclear and yields uniformly poor results, particularly in patients with advanced lesions. Clinical trials are needed... - Improved survival of Asians with corpus cancer compared with whites: an analysis of underlying factorsMallory M Zhang
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford Cancer Center, Stanford University School of Medicine, CA 94305, USA
Obstet Gynecol 107:329-35. 2006..level of evidence: ii-2... - Patients with malignancy requiring urgent therapy: CASE 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancerJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA
J Clin Oncol 23:6794-5. 2005 - Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinomaJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305-5317, USA
Gynecol Oncol 95:152-6. 2004..CONCLUSION: Clitoral-sparing vulvar cancer surgery does not compromise the rate of loco-regional control in patients and may be offered to selected women... - Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometriumJohn K Chan
Department of Obstetrics and Gynecology, University of California, Irvine-Medical Center, 101 The City Drive, Orange, CA 92868, USA
Gynecol Oncol 90:181-5. 2003..Thus, women with noninvasive UPSC should undergo a comprehensive staging procedure including omental sampling to determine the extent of disease... - Safety and efficacy of lenalidomide (Revlimid) in recurrent ovarian and primary peritoneal carcinomaMallory M Zhang
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, 300 Pasteur Drive, Room HH333, Stanford, CA 94305 5317, USA
Gynecol Oncol 105:194-8. 2007..The secondary objective is to evaluate the efficacy profile and quality of life (QOL) parameters in patients receiving this treatment... - Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat modelJohn K Chan
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford Cancer Center, 300 Pasteur Drive HH333, Stanford, CA 94305 5317, USA
Cancer Res 65:3243-8. 2005..Thus, EGFR blockade may ultimately prove to be a useful therapeutic tool in the treatment of cisplatin-sensitive and cisplatin-resistant ovarian cancers... - Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancerJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, 300 Pasteur Dr HH333, Stanford, CA 94305 5317, USA
Gynecol Oncol 99:20-5. 2005..To determine clinical or biological associations between mast cell density, blood clotting, angiogenesis, and survival of patients with advanced ovarian cancer... - Clinicopathologic features of six cases of primary cervical lymphomaJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA, USA
Am J Obstet Gynecol 193:866-72. 2005..Primary lymphoma of the uterine cervix is rare, with less than 60 cases reported. We present a series of 6 patients with cervical lymphoma and review the literature... - Clinical aspects of uterine papillary serous carcinomaChad A Hamilton
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, District of Columbia, USA
Curr Opin Obstet Gynecol 20:26-33. 2008..We review the demographic and clinicopathologic characteristics, and prognosis of women diagnosed with uterine papillary serous carcinoma, with a focus on clinical management... - Oral altretamine used as salvage therapy in recurrent ovarian cancerJohn K Chan
Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305 5317, USA
Gynecol Oncol 92:368-71. 2004..Altretamine has reported efficacy in the treatment of recurrent ovarian cancer following platinum-based therapy. This report presents the cases of two long-term survivors with recurrent ovarian cancer given oral altretamine... - Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes?John K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University Medical Center, Stanford Cancer Center 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
Gynecol Oncol 102:508-12. 2006..To analyze corpus cancer patients with a breast cancer history for risk of developing aggressive uterine histologic types... - Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical studyJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford Cancer Center, Stanford University, Stanford, California, USA
Clin Cancer Res 12:1859-67. 2006..Bispecific antibodies significantly enhanced the cytotoxicity of CIK cells in primary ovarian cancer cells and in our in vivo mouse model. The mechanism of cytolysis seems to be mediated in part by the NKG2D receptor... - Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblastsMichael Samoszuk
Department of Pathology and Laboratory Medicine, University of California, Irvine, California, USA
BMC Cancer 5:121. 2005..The purpose of this study was to test the hypothesis that mast cells that are present in fibrotic regions of cancer can suppress the growth of tumor cells through an indirect mechanism involving peri-tumoral fibroblasts... - A modified technique for insertion of intraperitoneal port for chemotherapyWen-Shiung Liou
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford Cancer Center, Stanford University School of Medicine, Stanford, California 94305-5317, USA
J Surg Oncol 90:247-8. 2005..An effective method that provides a reliable access to the IP cavity is needed. In this report, we describe a novel technique of IP port placement that may prevent access problems and decrease patient discomfort... - Juvenile granulosa cell tumor of the ovary associated with tuberous sclerosisHongyan Guo
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford University School of Medicine, 300 Pasteur Drive HH333, CA 94305, USA
Gynecol Oncol 102:118-20. 2006..She is currently free of disease 8 years after her recurrence. CONCLUSION: Treatment options and a review of the literature pertaining to juvenile ovarian granulosa cell tumors and tuberous sclerosis are discussed... - Innovations in fertility preservation for patients with gynecologic cancersWen-Shiung Liou
Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Stanford University School of Medicine, Palo Alto, California, USA
Fertil Steril 84:1561-73. 2005..For some women with gynecologic cancers, fertility-sparing treatment might be appropriate... - Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancerJohn K Chan
Division of Obstetrics and Gynecology, Stanford University School of Medicine, California, USA
Clin Cancer Res 10:8538-43. 2004..Lower MVD was an independent prognostic factor for decreased survival. Lower frequency of neovascularization in these cancers may contribute to the decreased survival observed in women >45 years of age... - Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat modelJohn K Chan
Beckman Laser Institute, University of California-Irvine, Irvine, CA 92612, USA
Gynecol Oncol 87:64-70. 2002..Human trials are indicated... - Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomyDaniel S Kapp
Division of Radiation Therapy, Department of Radiation Oncology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, California 94305 5847, USA
Cancer 112:820-30. 2008.... - Outcomes of women with metachronous breast and ovarian carcinomasWen-Shiung Liou
Department of Gynecology and Obstetrics, Stanford Cancer Center, Stanford University School of Medicine, 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
Gynecol Oncol 103:190-4. 2006..Since half of the women had their second cancer beyond 5 years, continued surveillance of these high risk patients is recommended...